Caris Life Sciences, Inc.
CAI
Analytical Summary
Caris Life Sciences, Inc. faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.
4-Year Financial Trajectory
AnnualBullish Indicators
- No bullish signals detected.
Bearish Risks
- Profit Margin (%)Profit Margin (%) is in the bottom quartile
Health Breakdown
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ |
|---|---|---|---|---|
| Revenue Growth YoY (%) |
97.0%
Excellent
Excellent
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Above avg (+1112%)
|
34.7%
Excellent
Excellent
Year-over-year change in total revenue
Optimal:
> 10%
vs Sector:
Above avg (+333%)
|
— | — |
| EPS Growth YoY (%) |
69.8%
Excellent
Excellent
Year-over-year change in earnings per share
Optimal:
> 10%
|
19.5%
Good
Good
Year-over-year change in earnings per share
Optimal:
> 10%
|
— | — |
| Net Income Growth YoY (%) |
75.8%
Excellent
Excellent
Year-over-year change in net income |
17.4%
Good
Good
Year-over-year change in net income |
— | — |
| FCF Growth YoY (%) | N/M |
16.3%
Good
Good
Year-over-year change in free cash flow |
— | — |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ |
|---|---|---|---|---|
| Operating Margin (%) (%) |
5.6%
Weak
↑
Weak
Improving
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-63%)
|
-62.4%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-516%)
|
-104.4%
Weak
Weak
Operating income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-796%)
|
— |
| Effective Tax Rate (%) (%) |
0.0%
Excellent
→
Excellent
Stable
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
0.0%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
0.0%
Excellent
Excellent
Actual taxes paid relative to pre-tax income
Optimal:
15-25%
|
— |
| Profit Margin (%) (%) |
-8.4%
Weak
↑
Weak
Improving
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-170%)
|
-68.4%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-670%)
|
-111.5%
Weak
Weak
Net income as a percentage of revenue
Optimal:
> 15%
vs Sector:
Below avg (-1029%)
|
— |
| FCF Margin (%) (%) |
8.2%
Caution
↑
Caution
Improving
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
-61.5%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
-97.5%
Weak
Weak
Free cash flow as a percentage of revenue
Optimal:
> 10%
|
— |
| FCF / Net Income (x) |
-0.98x
Weak
↓
Weak
Declining
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.90x
Caution
Caution
Free cash flow relative to reported net income
Optimal:
> 1x
|
0.87x
Caution
Caution
Free cash flow relative to reported net income
Optimal:
> 1x
|
— |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ |
|---|---|---|---|---|
| Return on Invested Capital (%) |
4.7%
Caution
↓
Caution
Declining
Return earned on debt + equity capital invested
Optimal:
> 10%
|
12.1%
Good
Good
Return earned on debt + equity capital invested
Optimal:
> 10%
|
14.9%
Good
Good
Return earned on debt + equity capital invested
Optimal:
> 10%
|
— |
| Return on Capital (%) (%) |
4.0%
Caution
Caution
Operating profit relative to total assets
Optimal:
> 10%
|
-74.8%
Weak
Weak
Operating profit relative to total assets
Optimal:
> 10%
|
— | — |
| Return on Common Equity (%) (%) |
-11.8%
Weak
↓
Weak
Declining
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-179%)
|
11.3%
Fair
Fair
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Below avg (-25%)
|
15.9%
Good
Good
Profit generated per dollar of shareholder equity
Optimal:
> 15%
vs Sector:
Above avg (+6%)
|
— |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ |
|---|---|---|---|---|
| Debt to Equity (x) |
0.66x
Fair
Fair
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Above avg (+9%)
|
-0.15x
Excellent
Excellent
Total debt relative to shareholder equity
Optimal:
< 0.6x
vs Sector:
Below avg (-125%)
|
— | — |
| Interest Coverage (x) |
0.79x
Weak
↑
Weak
Improving
Operating income divided by interest expense
Optimal:
> 5x
|
-5.14x
Weak
Weak
Operating income divided by interest expense
Optimal:
> 5x
|
-10.13x
Weak
Weak
Operating income divided by interest expense
Optimal:
> 5x
|
— |
| Net Debt (USD) | $-417.82M | $309.19M | — | — |
| Debt / EBITDA (x) |
5.59x
Weak
Weak
Debt relative to earnings before interest, taxes, depreciation
Optimal:
< 2x
|
-1.79x
Excellent
Excellent
Debt relative to earnings before interest, taxes, depreciation
Optimal:
< 2x
|
— | — |
| Metric | FY 2025 Dec 31, 2025 10-K ↗ | FY 2024 Dec 31, 2024 10-K ↗ | FY 2023 Dec 31, 2023 10-K ↗ | FY 2022 Dec 31, 2022 10-K ↗ |
|---|---|---|---|---|
| Sales/Revenue/Turnover (USD) | $812.03M | $412.26M | $306.13M | — |
| Depreciation Expense (USD) | $22.61M | $48.91M | $49.00M | — |
| Net Income, GAAP (USD) | $-68.09M | $-281.89M | $-341.42M | — |
| Operating Cash Flow (USD) | $83.16M | $-245.20M | $-276.10M | — |
Secondary lens
Benchmark Lens
Compare CAI against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare CAI against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for CAI
No bullish signals detected
Profit Margin (%) is in the bottom quartile
Percentile Rankings
How CAI compares to all companies
Peer Comparison
CAI vs similar peers
Compare CAI with peers
Stack CAI against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 1 week ago 4 years · 11 quarters